SC
TYRA icon

Steven Cohen’s Tyra Biosciences TYRA Stock Holding History

Steven Cohen’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-38,850
Closed -$1.49M – 4602
2026
Q1 		$1.49M Sell
38,850
-835,342
-96% -$27M ﹤0.01% 2507
2025
Q4 		$23M Buy
874,192
+592,160
+210% +$10.9M 0.03% 795
2025
Q3 		$3.95M Buy
282,032
+57,332
+26% +$654K 0.01% 1164
2025
Q2 		$2.15M Buy
224,700
+175,100
+353% +$1.66M ﹤0.01% 1280
2025
Q1 		$461K Buy
49,600
+36,817
+288% +$476K ﹤0.01% 1650
2024
Q4 		$178K Buy
+12,783
New +$232K ﹤0.01% 1910

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Steven Cohen's TYRA Position: Q2 2026 in Review

Steven Cohen sold out of Tyra Biosciences (TYRA) in Q2 2026, closing a stake of 38,850 shares — an estimated $1.49M sold.

Steven Cohen first reported a position in TYRA in Q4 2024 and held it in 6 quarters. The position peaked at $23M in Q4 2025. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Steven Cohen reported no remaining Tyra Biosciences position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 38,850 Tyra Biosciences shares in Q2 2026, an estimated $1.49M.
  • Steven Cohen first reported a position in Tyra Biosciences in Q4 2024 and held it in 6 quarters.
  • Steven Cohen's Tyra Biosciences position peaked at $23M in Q4 2025.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.